REGISTER

FR
Search
×
FR

Placeholder headline

This is just a placeholder headline

API SPEC 14L: Lock Mandrels and Landing Nipples : Reaffirmed

$

273

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 20F: Corrosion Resistant Bolting for Use in the Petroleum and Natural Gas Industries : Reaffirmed

$

169

BUY NOW

Placeholder headline

This is just a placeholder headline

API TR 5NCL Nickel Content Limits for API 5CT Sour Service Products

$

149

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 19ICD: Inflow Control Devices : Reaffirmed

$

189

BUY NOW

Placeholder headline

This is just a placeholder headline

API MPMS CH 23.2: Reconciliation of Liquid Tank Car(s) Quantities : Reaffirmed

$

218

BUY NOW

Placeholder headline

This is just a placeholder headline

API SPEC 16A: Specification for Drill-through Equipment

$

322

BUY NOW

Placeholder headline

This is just a placeholder headline

API RP 13B-2: Field Testing Oil-based Drilling Fluids wA1

$

388

BUY NOW

ISO 17822:2020

ISO 17822:2020 In vitro diagnostic test systems – Nucleic acid amplification-based examination procedures for detection and identification of microbial pathogens – Laboratory quality practice guide

CDN $312.00

SKU: c56685d4e56c Categories: ,

Description

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.

Edition

1

Published Date

2020-12-01

Status

PUBLISHED

Pages

39

Language Detail Icon

English

Format Secure Icon

Secure PDF

Abstract

This document describes the particular clinical laboratory practice requirements to ensure the quality of detection, identification and quantification of microbial pathogens using nucleic acid amplification tests (NAAT).

It is intended for use by laboratories that develop, and/or implement and use, or perform NAAT for medical, research or health-related purposes. This document does not apply to the development of in vitro diagnostic (IVD) medical devices by manufacturers. However, it does include verification and validation of such devices and/or the corresponding processes when implemented and used by the laboratories.

Previous Editions

Can’t find what you are looking for?

Please contact us at: